TRI-ESTARYLLA
Generic: NORGESTIMATE AND ETHINYL ESTRADIOL
XiromedManufacturer
2013-01-30Original Approval
TRI-ESTARYLLA is FDA application ANDA090793, sponsored by XIROMED. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
PREGNANCY ON ORAL CONTRACEPTIVE
56 reports
2
DRUG INEFFECTIVE
45 reports
3
NAUSEA
38 reports
4
DRUG DOSE OMISSION
36 reports
5
MATERNAL EXPOSURE DURING PREGNANCY
36 reports
6
NO ADVERSE EVENT
31 reports
7
PRODUCT QUALITY ISSUE
30 reports
8
DRUG INTERACTION
29 reports
9
VOMITING
29 reports
10
HEADACHE
28 reports